🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
Gateway Medical Research, Inc.
Start Date
2003-07
Trial ID
NCT00648583
Treatments Being Tested
To demonstrate the relative bioavailability study of Ondansetron HCl 24 mg ...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00946387
This clinical trial aims to determine the effects of a 6-day low-dose methy...
Status
Recruiting
Location
Emory Musculoskeletal Institute, Emory Orthopaedics & Spine Center
Start Date
2025-01-27
Trial ID
NCT06780202
Treatments Being Tested
To demonstrate the relative bioavailability study of Ondansetron HCl 24 mg ...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00947128
Randomized, Placebo-Controlled, Phase 3 Trial of RHB-102 (BEKINDA) (Ondanse...
Status
Completed
Location
Kern Medical Center
Start Date
2014-12-08
Trial ID
NCT02246439
Treatments Being Tested
Single-dose cross over comparative bioavailability of Ondansetron 24 mg oDT...
Status
Completed
Location
Algorithme Pharma
Start Date
2003-10
Trial ID
NCT00659074
Treatments Being Tested
Background: The new drug LMP744 (NSC 706744) damages deoxyribonucleic acid...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-02-27
Trial ID
NCT03030417
This study will evaluate the safety and tolerability based on the incidence...
Status
Completed
Location
Lotus Clinical Research, LLC
Start Date
2017-09-12
Trial ID
NCT03254459
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
Gateway Medical Research, Inc.
Start Date
2003-07
Trial ID
NCT00649532
Treatments Being Tested